Vimarsana
Biggest News Aggregation in the World

Restylane Silk News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Restylane Silk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Restylane Silk Today - Breaking & Trending Today

Skin Booster Injectables Explained: What Is Skinvive, Profhilo? Experts Weigh In - Vimarsana News

Skin Booster Injectables Explained: What Is Skinvive, Profhilo? Experts Weigh In

Skin boosters are a new class of injectable coming to the U.S. this fall. So what are skin boosters like Skinvive and Profhilo, and what do they do to skin? Expert dermatologists weigh in.

What to Know About Lip Filler, According to a Dermatologist - Vimarsana News

What to Know About Lip Filler, According to a Dermatologist

Here's everything you need to know about getting lip filler for the first time, including how soon you'll see results and how much it actually hurts.

Anti-Aging Tips for Lip Lines and Wrinkles - Vimarsana News

Anti-Aging Tips for Lip Lines and Wrinkles

There's more you could be doing to make your lips look younger, fresher, and plumper. Here, four dermatologists spill tips and tricks for anti-aging your lips.

Galderma Receives FDA Approval for Restylane® Defyne for Chin Augmentation - Vimarsana News

Galderma Receives FDA Approval for Restylane® Defyne for Chin Augmentation

Galderma Receives FDA Approval for Restylane® Defyne for Chin Augmentation Represents second approved indication for Restylane Defyne in U.S.; expands Galderma Aesthetics' growing Restylane product portfolio News provided by Share this article Share this article FORT WORTH, Texas, Feb. 2, 2021 /PRNewswire/ -- Galderma announces that the U.S. Food and Drug Administration (FDA) has approved Restylane ® Defyne for the augmentation and correction of mild to moderate chin retrusion for adults over the age of 21. 1 In 2020 alone, online searches for chin enhancement increased by 185 percent, rei...